Filing Details

Accession Number:
0001209191-14-034785
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-16 19:05:20
Reporting Period:
2014-05-14
Filing Date:
2014-05-16
Accepted Time:
2014-05-16 19:05:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130591 Xenoport Inc XNPT Pharmaceutical Preparations (2834) 943330837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202769 L Paul Berns C/O Xenoport, Inc.
3410 Central Expressway
Santa Clara CA 95051
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-14 5,000 $0.00 7,500 No 4 M Direct
Common Stock Disposition 2014-05-15 2,500 $3.66 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-employee director stock unit Disposition 2014-05-14 5,000 $0.00 5,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2014.
  2. Each restricted stock unit represents a contingent right to receive one share of XenoPort, Inc. common stock.
  3. The restricted stock units shall cliff vest in full on the one-year anniversary of the grant date, May 14, 2013.